GILD:NSD-Gilead Sciences Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 97.9

Change

+6.21 (+6.77)%

Market Cap

USD 111.44B

Volume

0.01B

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

+0.84 (+1.32%)

USD 203.14B
AMGN Amgen Inc

+0.12 (+0.04%)

USD 172.97B
SNY Sanofi ADR

+0.47 (+0.92%)

USD 134.67B
BIIB Biogen Inc

-0.48 (-0.28%)

USD 25.32B
GRFS Grifols SA ADR

+0.45 (+4.97%)

USD 6.92B
AMRN Amarin Corporation PLC

-0.02 (-2.84%)

USD 0.26B
MIRA MIRA Pharmaceuticals, Inc. Com..

-0.01 (-0.59%)

USD 0.03B
SCLX Scilex Holding Company

-0.09 (-8.79%)

N/A
SCLXW Scilex Holding Company

-0.12 (-25.70%)

N/A

ETFs Containing GILD

BBH VanEck Biotech ETF 9.56 % 0.35 %

+1.40 (+0.66%)

USD 0.43B
IBBQ Invesco Nasdaq Biotechnol.. 9.46 % 0.00 %

+0.35 (+0.66%)

USD 0.04B
2B70:F iShares NASDAQ US Biotech.. 9.45 % 0.00 %

+0.05 (+0.66%)

USD 0.52B
2B70:XETRA iShares Nasdaq US Biotech.. 9.45 % 0.00 %

+0.06 (+0.66%)

USD 0.52B
BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

+0.10 (+0.66%)

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
BIS ProShares UltraShort Nasd.. 7.41 % 0.95 %

-0.38 (0.66%)

USD 3.52M
BIB ProShares Ultra Nasdaq Bi.. 6.47 % 0.95 %

+1.67 (+0.66%)

USD 0.08B
XDNA:CA iShares Genomics Immunolo.. 5.14 % 0.00 %

+0.78 (+0.66%)

CAD 5.26M
TBG EA Series Trust 4.09 % 0.00 %

+0.06 (+0.66%)

USD 0.08B
UDI USCF ETF Trust 4.00 % 0.00 %

-0.21 (0.66%)

N/A
JPHC:PA Amundi Index Solutions - .. 3.90 % 0.00 %

+0.41 (+0.66%)

USD 5.51M
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

+1.10 (+0.66%)

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

+0.78 (+0.66%)

USD 5.44M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.08B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.80M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.05B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 5.78B
BAMD 3.64 % 0.00 %

N/A

N/A
FBT:LSE First Trust Global Funds .. 3.54 % 0.00 %

+11.50 (+0.66%)

USD 8.45M
FBTU:LSE First Trust Global Funds .. 3.54 % 0.00 %

+0.30 (+0.66%)

USD 8.45M
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

+0.05 (+0.66%)

N/A
MDLV 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.90 % 0.00 %

-0.03 (0.66%)

USD 0.05B
MOTU:LSE VanEck Morningstar US Wid.. 2.79 % 0.00 %

+0.15 (+0.66%)

USD 0.05B
MOAT:AU VanEck Morningstar Wide M.. 2.69 % 0.00 %

-1.80 (0.66%)

USD 0.98B
MHOT:AU VanEck Morningstar Wide M.. 2.63 % 0.00 %

+0.35 (+0.66%)

N/A
CURE:AU ETFS S&P Biotech ETF 2.56 % 0.00 %

-0.93 (0.66%)

USD 0.04B
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

+0.01 (+0.66%)

N/A
XDGI:XETRA Xtrackers MSCI Global SDG.. 2.26 % 0.00 %

+0.33 (+0.66%)

USD 0.01B
TDGB:LSE VanEck Morningstar Develo.. 2.26 % 0.00 %

+0.01 (+0.66%)

USD 1.05B
WTD9:F WisdomTree US Equity Inco.. 2.24 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 2.24 % 0.00 %

+0.12 (+0.66%)

USD 1.34M
WTEU:F WisdomTree US Equity Inco.. 2.24 % 0.00 %

+0.16 (+0.66%)

USD 0.11B
GOAT:AU VanEck Morningstar World .. 2.12 % 0.00 %

-0.56 (0.66%)

USD 0.04B
DHS:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
2B78:XETRA iShares Healthcare Innova.. 2.02 % 0.00 %

+0.04 (+0.66%)

USD 1.14B
HEAL:SW iShares Healthcare Innova.. 1.85 % 0.00 %

-0.01 (0.66%)

N/A
HWVS:LSE HSBC MSCI World Value ESG.. 1.82 % 0.00 %

+0.08 (+0.66%)

USD 0.22B
RSPH Invesco S&P 500® Equal.. 1.80 % 0.00 %

+0.18 (+0.66%)

USD 0.90B
WEBA:XETRA Amundi US Tech 100 Equal .. 1.22 % 0.00 %

+0.08 (+0.66%)

USD 0.60B
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

+0.03 (+0.66%)

N/A
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

+0.02 (+0.66%)

N/A
UBBB:PA Amundi Index Solutions - .. 0.46 % 0.00 %

+0.28 (+0.66%)

USD 0.13B
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

+0.03 (+0.66%)

N/A
CBND 0.00 % 0.16 %

N/A

N/A
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

-0.34 (0.66%)

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+1.42 (+0.66%)

USD 7.19B
IBCD 0.00 % 0.10 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

+2.37 (+0.66%)

USD 0.91B
MOAT 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

+0.08 (+0.66%)

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

-0.24 (0.66%)

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

+0.91 (+0.66%)

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

+0.49 (+0.66%)

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

+0.08 (+0.66%)

CAD 0.09B
JIGB 0.00 % 0.14 %

N/A

N/A
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

+0.30 (+0.66%)

USD 0.14B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

+0.27 (+0.66%)

USD 1.77B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.11 (+0.66%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.04 (+0.66%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

+0.10 (+0.66%)

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
SPYD SPDR® Portfolio S&P 500 .. 0.00 % 0.08 %

-0.11 (0.66%)

USD 6.79B
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

+0.57 (+0.66%)

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

+0.13 (+0.66%)

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

+0.10 (+0.66%)

N/A
FCW:CA 0.00 % 0.90 %

N/A

N/A
SPDV AAM S&P 500 High Dividend.. 0.00 % 0.29 %

+0.06 (+0.66%)

USD 0.06B
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-11.20 (0.66%)

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.05 (+0.66%)

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+0.03 (+0.66%)

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

+3.50 (+0.66%)

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

-14.50 (0.66%)

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+1.38 (+0.66%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.13 (+0.66%)

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

-5.50 (0.66%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.41 (+0.66%)

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

-4.00 (0.66%)

N/A
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.20 (+0.66%)

USD 0.05B
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

-0.10 (0.66%)

USD 0.05B
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

+0.04 (+0.66%)

USD 0.85M
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

-0.09 (0.66%)

USD 0.11B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
HDLB ETRACS Monthly Pay 2xLeve.. 0.00 % 0.00 %

-0.18 (0.66%)

USD 8.65M
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

+0.08 (+0.66%)

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
SIXA 6 Meridian Mega Cap Equit.. 0.00 % 0.00 %

+0.11 (+0.66%)

USD 0.28B
SIXH ETC 6 Meridian Hedged Equ.. 0.00 % 0.00 %

-0.06 (0.66%)

USD 0.43B
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

+0.03 (+0.66%)

USD 1.13B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.01 (+0.66%)

CAD 0.09B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

+0.24 (+0.66%)

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

+0.29 (+0.66%)

USD 0.02B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.10 (+0.66%)

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -96.22% 10% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -96.22% 10% F 1% F
Trailing 12 Months  
Capital Gain -95.92% 10% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -95.92% 10% F 1% F
Trailing 5 Years  
Capital Gain -95.32% 14% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -95.32% 14% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain 0.15% 70% C- 39% F
Dividend Return 3.76% 70% C- 46% F
Total Return 3.61% 80% B- 74% C
Risk Return Profile  
Volatility (Standard Deviation) 23.57% 60% D- 72% C
Risk Adjusted Return 15.97% 70% C- 49% F
Market Capitalization 111.44B 63% D 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.